Dr. Hönle AG: Hönle withdraws forecast due to the Covid-19 pandemic

Graefelfing, Munich (pta021/27.04.2020/11:30 UTC+2) The managing board of Dr. Hönle AG today decided to withdraw the outlook for the 2019/2020 financial year. The impact of the Covid-19 pandemic on the business development of the Hönle Group cannot be estimated currently.

The international lockdown measures and the impairment of production processes lead to a significant deterioration in the overall economic outlook. The ongoing Covid-19 pandemic is therefore expected to influence the Hönle Group's sales and earnings development in the 2019/2020 financial year.

The managing board plans to update the financial outlook as soon as the economic impact of the pandemic is quantifiable in a better way. The half-year report will be published on May 15, 2020, as planned.

About Hönle
The Dr. Hönle AG is a listed technology company based in Graefelfing near Munich. With more than 500 employees, the Hönle Group develops innovative solutions for a wide variety of industrial manufacturing processes. A main focus of the business activity is the development and sale of industrial adhesives and sealings. Furthermore, devices for drying inks and coatings, curing adhesives and plastics as well as for surface disinfection and sunlight simulation are manufactured. In addition, the company produces UV lamps for water disinfection and produces tubes and semi-finished products made of quartz glass, which are used in different industries. The Hönle Group supplies technology and world market leaders and is represented in more than 20 countries by own companies and sales partners.

(end)

Emitter:	Dr. Hönle AG Lochhamer Schlag 1 82166 Gräfelfing/München Germany
Contact Person:	Peter Weinert
Phone:	+49 89 85608-173
E-Mail:	peter.weinert@hoenle.de
Website:	www.hoenle.de
ISIN(s):	DE0005157101 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate